Medical marketing news, white papers, reports, and events from PharmaLeaders. New content daily, on our website and delivered right to your inbox.
Eyeforpharma 2017 By: Kim Fitzgerald Eyeforpharma, hosted at the Sheraton in Downtown, Philadelphia from April 20-21 delivered yet again, with over 550 industry leading executives, 50 pharmaceutical companies, and 25 exhibitors. In addition, the conference provided attendees 9 engaging workshops and 110 expert speakers. 47 companies sponsored the event including, QuintilesIMS, a leading global healthcare provider of integrated ... Read More
Vitals Index Study Reveals Stark Generational Differences When It Comes to Attitudes About Health Care Millennials have a high-degree of trust; Gen Xers are the most skeptical A national survey released today by Vitals found that, when it comes to attitudes about health care, a lot may depend on your age. Separated by decades, generations are often defined by researchers in their own unique terms. Now, a Vitals Index study that surveyed ... Read More
eyeforpharma’s latest whitepaper shows why GSK’s ‘New Commercial Model’ is bringing results PRESS RELEASE Putting resources behind the rhetoric of customer-centricity can pay dividends, as eyeforpharma’s new whitepaper documents in its exploration of the impact of GSK’s ‘New Commercial Model’. While customer-centricity is a buzzword, structuring change around this objective is still consider controversial. That’s why GSK’s new ‘Ethics-first’ approach to commercialization, which includes the decoupling of incentives from ... Read More
Patient-Provider Dialogue The most important conversation a patient has is with his or her provider. And when there are gaps in the treatment discussion, your brand may be missing an opportunity. Building on our behavioral science expertise, we combed through published research and conducted some of our own. We found ways to improve the treatment discussion between patients ... Read More
Mental Health: An Insurance Industry Perspective How payers look at priorities for care in a time of policy uncertainty and growing concerns in the patient advocacy community. No group of stakeholders wields greater influence over patient access to medicines than payers making reimbursement and formulary decisions. Even in a time of policy upheaval in Washington, health plans must make sure members get ... Read More